Charles River Laboratories announced several key expansions to its global Biologics Testing Solutions infrastructure to support the characterization, development, and release of biologics and biosimilars. Growth in this industry has led to increased demand for outsourced services, providing an opportunity for Charles River to enhance capacity and capabilities in support of client needs.
To increase its capacity and support higher demand, Charles River recently added a new, 73,000 square-foot facility on Devon Park Road in Wayne, Pennsylvania. This facility will more than double the laboratory space available at Charles River’s existing facilities in Malvern and King of Prussia, Pennsylvania.
Certain laboratory operations conducted at Charles River’s Malvern and King of Prussia sites will begin to move to Devon Park early in the third quarter of 2018. The formal transfer of assays will be done in phases, and during the transition, both the Malvern and King of Prussia facilities will remain fully operational to ensure there will be no interruption of services.